Gastrojejunal Anastomotic Reduction for Weight Regain in Roux-en-y Gastric Bypass Patients: Physiological, Behavioral, and Anatomical Effects of Endoscopic Suturing and Sclerotherapy
Overview
Affiliations
Background: Weight regain is common after Roux-en-Y gastric bypass.
Objectives: To assess the mechanisms of weight loss after 2 gastrojejunal anastomotic reduction (GJAR) procedures to treat weight regain.
Setting: University hospital, United States.
Methods: Forty-three Roux-en-Y gastric bypass patients with weight regain were prospectively enrolled. Weight, ghrelin levels, responses to the 21-item three-factor eating questionnaire, and gastrojejunal anastomotic diameter were assessed. Nine patients underwent endoscopic suturing and 34 patients underwent sclerotherapy. At 3 months, weight, ghrelin levels, eating behavior, and outlet diameter were reassessed.
Results: Patients were aged 47±10 years and regained 43%±26% of maximal lost weight. Ghrelin levels were 123±106 ng/mL and outlet diameter was 21±6.3 mm. At 3 months, the entire cohort lost 4.1%±5.9% of total weight (TBW) and showed improvement in cognitive eating habits (P<.01). Endoscopic suturing and sclerotherapy patients lost 10.4%±2.2% TBW and 2.7%±5.5% TBW (P<.01), respectively. Suturing and sclerotherapy reduced the outlet diameter by 15.0±6.7 mm and 2.6±5.7 mm (P<.01). Ghrelin levels increased after suturing by 46±55 ng/mL and decreased by 37±110 ng/mL after sclerotherapy (P = .02). Suturing resulted in greater improvement in cognitive eating behavior than sclerotherapy (P = .03). Reduction in outlet size and changes in cognitive and emotional eating behaviors were predictors of weight loss after GJAR on a univariate analysis. On a multivariate analysis, the only predictor of weight loss was a reduction in outlet size (P< .01).
Conclusions: Endoscopic suturing resulted in greater reduction in outlet size, improvement in eating behavior, and weight loss than sclerotherapy. Reduction of anastomosis size was a significant predictor of weight loss after GJAR.
Xiao H, Du Y, Tan Y, Ren Y Front Nutr. 2025; 11:1510403.
PMID: 39764413 PMC: 11700827. DOI: 10.3389/fnut.2024.1510403.
A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going.
Mauro A, Lusetti F, Scalvini D, Bardone M, De Grazia F, Mazza S Medicina (Kaunas). 2023; 59(3).
PMID: 36984637 PMC: 10052707. DOI: 10.3390/medicina59030636.
Bariatric endoscopy: from managing complications to primary metabolic procedures.
Dang J, Kim G, Kroh M J Minim Invasive Surg. 2023; 26(1):1-8.
PMID: 36936036 PMC: 10020740. DOI: 10.7602/jmis.2023.26.1.1.
Endoscopic Management of Weight Recurrence Following Bariatric Surgery.
Abboud D, Yao R, Rapaka B, Ghazi R, Ghanem O, Abu Dayyeh B Front Endocrinol (Lausanne). 2022; 13:946870.
PMID: 35909531 PMC: 9329792. DOI: 10.3389/fendo.2022.946870.
Endoscopic therapy of weight regain after bariatric surgery.
Bulajic M, di Prampero S, Boskoski I, Costamagna G World J Gastrointest Surg. 2022; 13(12):1584-1596.
PMID: 35070065 PMC: 8727177. DOI: 10.4240/wjgs.v13.i12.1584.